SCOTTSDALE, ARIZ. – DEC. 9, 2019 – Aural Analytics, Inc., a privately held digital health company developing the world’s most advanced speech analytics platform, today announced its participation in the Consumer Technology Association (CTA) initiative to define new standards and best practices for the use of artificial intelligence (AI) in healthcare.
The CTA AI in Healthcare working group is a collaborative effort of more than 40 stakeholders – digital health and technology companies, clinicians, manufacturers, agencies and associations, academic institutions and health organizations – tackling issues at the intersection of healthcare and technology.
“Aural Analytics is pleased to be working alongside an impressive roster of innovators from across the ecosystem to define security and privacy standards governing how all modalities, including voice, will be used in healthcare,” said Visar Berisha, Ph.D., co-founder, chief analytics officer, Aural Analytics and a member of the working group.
Aural Analytics’ proprietary platform tracks and analyzes vocal biomarkers (components of speech) that detect and measure subtle, clinically relevant speech changes in patients with neurological conditions that impact speech and language.
“Advancing the tremendous potential of artificial intelligence within healthcare requires a rigorous approach and a common understanding of the challenges such as privacy and confidentiality,” said Daniel Jones, co-founder, chief executive officer, Aural Analytics. “We support CTA and its strategic approach to setting standards in voice and other important modalities that will have far reaching impact within the context of healthcare.”
“Since the initiative was launched in April 2019, the working group has made significant progress in developing recommendations for common terminology and methods for data management and oversight,” said Rene Quashie, vice president, digital health policy and regulatory affairs, CTA. “The group is charged with developing standards for complex applications, with the ultimate goal being improving patient outcomes and reducing healthcare costs.”
Aural Analytics, Inc. is a privately held digital health company developing the world’s most advanced speech analytics platform, built on a foundation of 25 years of speech neuroscience research and data. The Company’s platform technology is based on pioneering research from Arizona State University and reinforced by multiple high-caliber peer-reviewed publications. Winners of the 2017 Global SCRIP Award for Best Technology in Clinical Trials, Aural Analytics’ first-to-market technology platform powers health applications all over the world. The Company maintains headquarters in Scottsdale, Ariz. For more information, please visit auralanalytics.com or follow Aural Analytics on Twitter, LinkedIn, Medium and Facebook.
Consilium Strategic Communications US Inc.